Furthermore, while some key findings resonate with those from studies involving type 2 diabetes patients [42,43], our study was restricted to type 1 diabetes patients, and, more specifically, to those converted to flexible intensive insulin therapy. This evidence concerns the gene INS and type 2 diabetes mellitus.